PRAXIS PRECISION MEDICINES, INC. Accrued Liabilities, Current
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Accrued Liabilities, Current of $24.59 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $24.59M.
- 2026-03-31: Accrued Liabilities, Current $17.65M.
- 2025-12-31: Accrued Liabilities, Current $35.03M.
- 2025-09-30: Accrued Liabilities, Current $21.63M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $24.59M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $17.65M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $35.03M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $21.63M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $19.02M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $15.55M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $23.76M 10-K · filed 2026-02-19 |
| 2024-09-30 | $15.46M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $10.06M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $6.98M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $7.42M 10-K · filed 2025-02-28 |
| 2023-09-30 | $6.98M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $13.32M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $9.35M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $15.85M 10-K · filed 2024-03-05 |
| 2022-09-30 | $17.88M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $25.77M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $30.93M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $26.84M 10-K · filed 2023-02-07 |
| 2021-09-30 | $16.53M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $7.83M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $7.39M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $10.87M 10-K · filed 2022-02-28 |
| 2020-09-30 | $6.19M 10-Q · filed 2020-11-23 |
| 2019-12-31 | $3.46M 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |